{"id":122640,"date":"2024-04-18T12:44:29","date_gmt":"2024-04-18T07:14:29","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=122640"},"modified":"2024-04-18T12:44:34","modified_gmt":"2024-04-18T07:14:34","slug":"stock-hits-10-upper-circuit-after-ashish-kacholia-buys-3-1-stake-do-you-own-it","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/stock-hits-10-upper-circuit-after-ashish-kacholia-buys-3-1-stake-do-you-own-it\/","title":{"rendered":"Stock hits 10% upper circuit after Ashish Kacholia buys 3.1% stake; Do you own it?"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-2200981992\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>Shares of this Pharma stock under the \u2018micro-cap\u2019 category hit its 10 percent upper circuit in Thursday\u2019s trading session after Mr. Ashish Kacholia, one of the well-known ace investors based in India, bought a fresh stake in the company during the financial quarter ended March 2024.&nbsp;<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-1968540529\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><p>With a market capitalization of Rs 197 crores, the stocks of <strong><a href=\"https:\/\/portal.tradebrains.in\/stock\/531569\/standalone\" target=\"_blank\" rel=\"noreferrer noopener\">Sanjivani Paranteral Limited<\/a><\/strong> started its trading session on Thursday hitting the 10 percent upper circuit at Rs 168.60, and, after some volatility, the company\u2019s stock bounced back and settled at its circuit price. The scrip is inching towards its 52-week high price of Rs 188.35 apiece.\u00a0<\/p><p>Such sharp movements in the company\u2019s share price were witnessed after Mr. Ashish Kacholia, one of the well-known ace investors based in India, bought a fresh stake in Sanjivani Paranteral Limited.&nbsp;<\/p><p>According to the latest filings available, the ace investor subscribed to 3.70 lakh equity shares of Sanjivani Paranteral Limited equivalent to a 3.17 percent stake in the company. Currently, the holding value of his investment stands at Rs 6.20 crores.&nbsp;<\/p><div class=\"trade-content_5\" id=\"trade-2268276088\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>During the recent financial quarters, the company\u2019s basic business parameters, viz, its operating revenues as well as after-tax profits, showed some marginal movements in opposing directions.&nbsp;<\/p><p>The former, on one end, jumped from Rs 14 crores during Q2FY24 to Rs 14.96 crores during Q3FY24, and the latter, on the other end, dipped slightly from Rs 1.71 crores to Rs 1.65 crores.&nbsp;<\/p><p>As per the latest presentations, the company\u2019s revenue mix reported a stellar performance pertaining to its \u2018Injectables\u2019 segment, shifting up from Rs 68.7 mn in Q2FY24 v\/s Rs 95.8 mn of revenue in Q3FY24. On a contrasting note, the other segments, i.e., the \u2018Oral\u2019 &amp; \u2018Nutraceutical\u201d segments, reported a dip in numbers.&nbsp;<\/p><p>Sanjivani Paranteral Limited is an India-based company engaged in the business of providing pharmaceutical products and services. With operations within as well as outside India, the company\u2019s product portfolio includes anti-biotic, anti-diabetic, anti-fungal, calcium and vitamin, cardiovascular, and others.<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written by Amit Madnani&nbsp;<\/strong><\/p><\/blockquote><h4 class=\"wp-block-heading\" id=\"h-disclaimer\">Disclaimer<\/h4><div class=\"wp-block-image\"><figure class=\"aligncenter size-medium\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.<\/strong><\/p><div class=\"trade-after-content\" id=\"trade-2524562423\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>Shares of this Pharma stock under the \u2018micro-cap\u2019 category hit its 10 percent upper circuit in Thursday\u2019s trading session after Mr. Ashish Kacholia, one of the well-known ace investors based in India, bought a fresh stake in the company during the financial quarter ended March 2024.&nbsp; With a market capitalization of Rs 197 crores, the [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":98971,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[15499,15498,948,936,3157,2597],"class_list":["post-122640","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-sanjivani-paranteral-latest-news","tag-sanjivani-paranteral-share-price","tag-stock-market","tag-stock-market-news","tag-stock-to-watch","tag-stocks-to-watch"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Stock hits 10% upper circuit after Ashish Kacholia buys 3.1% stake; Do you own it?<\/title>\n<meta name=\"description\" content=\"Shares of this Pharma stock under the \u2018micro-cap\u2019 category hit its 10 percent upper circuit in Thursday\u2019s trading session after Mr. Ashish Kacholia, one of the well-known ace investors based in India, bought a fresh stake in the company during the financial quarter ended March 2024.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/stock-hits-10-upper-circuit-after-ashish-kacholia-buys-3-1-stake-do-you-own-it\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Stock hits 10% upper circuit after Ashish Kacholia buys 3.1% stake; Do you own it?\" \/>\n<meta property=\"og:description\" content=\"Shares of this Pharma stock under the \u2018micro-cap\u2019 category hit its 10 percent upper circuit in Thursday\u2019s trading session after Mr. Ashish Kacholia, one of the well-known ace investors based in India, bought a fresh stake in the company during the financial quarter ended March 2024.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/stock-hits-10-upper-circuit-after-ashish-kacholia-buys-3-1-stake-do-you-own-it\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-18T07:14:29+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-18T07:14:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Stock hits 10% upper circuit after Ashish Kacholia buys 3.1% stake; Do you own it?\" \/>\n<meta name=\"twitter:description\" content=\"Shares of this Pharma stock under the \u2018micro-cap\u2019 category hit its 10 percent upper circuit in Thursday\u2019s trading session after Mr. Ashish Kacholia, one of the well-known ace investors based in India, bought a fresh stake in the company during the financial quarter ended March 2024.\u00a0\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/stock-hits-10-upper-circuit-after-ashish-kacholia-buys-3-1-stake-do-you-own-it\/\",\"url\":\"https:\/\/tradebrains.in\/features\/stock-hits-10-upper-circuit-after-ashish-kacholia-buys-3-1-stake-do-you-own-it\/\",\"name\":\"Stock hits 10% upper circuit after Ashish Kacholia buys 3.1% stake; Do you own it?\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/stock-hits-10-upper-circuit-after-ashish-kacholia-buys-3-1-stake-do-you-own-it\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/stock-hits-10-upper-circuit-after-ashish-kacholia-buys-3-1-stake-do-you-own-it\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"datePublished\":\"2024-04-18T07:14:29+00:00\",\"dateModified\":\"2024-04-18T07:14:34+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"Shares of this Pharma stock under the \u2018micro-cap\u2019 category hit its 10 percent upper circuit in Thursday\u2019s trading session after Mr. Ashish Kacholia, one of the well-known ace investors based in India, bought a fresh stake in the company during the financial quarter ended March 2024.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/stock-hits-10-upper-circuit-after-ashish-kacholia-buys-3-1-stake-do-you-own-it\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/stock-hits-10-upper-circuit-after-ashish-kacholia-buys-3-1-stake-do-you-own-it\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/stock-hits-10-upper-circuit-after-ashish-kacholia-buys-3-1-stake-do-you-own-it\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/stock-hits-10-upper-circuit-after-ashish-kacholia-buys-3-1-stake-do-you-own-it\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Stock hits 10% upper circuit after Ashish Kacholia buys 3.1% stake; Do you own it?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Stock hits 10% upper circuit after Ashish Kacholia buys 3.1% stake; Do you own it?","description":"Shares of this Pharma stock under the \u2018micro-cap\u2019 category hit its 10 percent upper circuit in Thursday\u2019s trading session after Mr. Ashish Kacholia, one of the well-known ace investors based in India, bought a fresh stake in the company during the financial quarter ended March 2024.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/stock-hits-10-upper-circuit-after-ashish-kacholia-buys-3-1-stake-do-you-own-it\/","og_locale":"en_US","og_type":"article","og_title":"Stock hits 10% upper circuit after Ashish Kacholia buys 3.1% stake; Do you own it?","og_description":"Shares of this Pharma stock under the \u2018micro-cap\u2019 category hit its 10 percent upper circuit in Thursday\u2019s trading session after Mr. Ashish Kacholia, one of the well-known ace investors based in India, bought a fresh stake in the company during the financial quarter ended March 2024.\u00a0","og_url":"https:\/\/tradebrains.in\/features\/stock-hits-10-upper-circuit-after-ashish-kacholia-buys-3-1-stake-do-you-own-it\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2024-04-18T07:14:29+00:00","article_modified_time":"2024-04-18T07:14:34+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_title":"Stock hits 10% upper circuit after Ashish Kacholia buys 3.1% stake; Do you own it?","twitter_description":"Shares of this Pharma stock under the \u2018micro-cap\u2019 category hit its 10 percent upper circuit in Thursday\u2019s trading session after Mr. Ashish Kacholia, one of the well-known ace investors based in India, bought a fresh stake in the company during the financial quarter ended March 2024.\u00a0","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/stock-hits-10-upper-circuit-after-ashish-kacholia-buys-3-1-stake-do-you-own-it\/","url":"https:\/\/tradebrains.in\/features\/stock-hits-10-upper-circuit-after-ashish-kacholia-buys-3-1-stake-do-you-own-it\/","name":"Stock hits 10% upper circuit after Ashish Kacholia buys 3.1% stake; Do you own it?","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/stock-hits-10-upper-circuit-after-ashish-kacholia-buys-3-1-stake-do-you-own-it\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/stock-hits-10-upper-circuit-after-ashish-kacholia-buys-3-1-stake-do-you-own-it\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","datePublished":"2024-04-18T07:14:29+00:00","dateModified":"2024-04-18T07:14:34+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"Shares of this Pharma stock under the \u2018micro-cap\u2019 category hit its 10 percent upper circuit in Thursday\u2019s trading session after Mr. Ashish Kacholia, one of the well-known ace investors based in India, bought a fresh stake in the company during the financial quarter ended March 2024.\u00a0","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/stock-hits-10-upper-circuit-after-ashish-kacholia-buys-3-1-stake-do-you-own-it\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/stock-hits-10-upper-circuit-after-ashish-kacholia-buys-3-1-stake-do-you-own-it\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/stock-hits-10-upper-circuit-after-ashish-kacholia-buys-3-1-stake-do-you-own-it\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/stock-hits-10-upper-circuit-after-ashish-kacholia-buys-3-1-stake-do-you-own-it\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Stock hits 10% upper circuit after Ashish Kacholia buys 3.1% stake; Do you own it?"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/122640","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=122640"}],"version-history":[{"count":1,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/122640\/revisions"}],"predecessor-version":[{"id":122641,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/122640\/revisions\/122641"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/98971"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=122640"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=122640"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=122640"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}